Piper Sandler Reiterates Overweight Rating on Harmony Biosciences Holdings Inc. (HRMY) After Analyst Event
Tweet Send to a Friend
Piper Sandler analyst David Amsellem reiterated an Overweight rating and $59.00 price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
